Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

Contact Us

Search

antiphospholipid syndrome

Immunology

Immunology Today—April 15, 2026

This week’s Immunology update highlights regulatory progress, clinical…

Immunology

Immunology Video Recap—December 3, 2025

This biweekly immunology video highlights major regulatory wins, evolving…

Immunology

Immunology Today—November 26, 2025

This week’s Immunology update spotlights key developments, regulatory…

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital Trends
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Healthcare and Pharma Trends
Rare Disease News
Health Mobile Apps Reports
Neuroscience News
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

AI in Healthcare and Digital Health Today—April 20, 2026
Lucid Diligence Brief: 10x Genomics launches Atera Platform
Lucid Diligence Brief: MeiraGTx re-acquires bota-vec rights from J&J
Lucid Diligence Brief: STORM Therapeutics $56 million Series C for Phase II in Sarcoma
Respiratory Today—April 17, 2026

Tags

AC Immune AMONDYS 45 antisense oligonucleotide Behcet’s disease Bivamelagon Cardiac Rehab Cardiovascular Risk CGRP chronic disease prevention clinical operations Committee for Medicinal Products for Human Use Competitive Intelligence Process Dermatomyositis Duchenne MD Duvakitug Efsubaglutide Alpha ESC2025 Exosome Vaccines GEO-MVA GLP1 drugs healthcare tech IgG4 Related Disease Immedica KRAS Macular degeneration Mantle Cell Lymphoma med tech Medtronic Diabetes Metformin Microplastics microRNA neurosymbolic AI Nutrition Science OM336 OncotoX-AML pediatric rare disease psychosis Rare pediatric disease designation RelabotulinumtoxinA robotic surgery RRMS Rusfertide Sjögrens Disease Sonelokimab Tabelecleucel

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

AI in Healthcare and Digital Health Today—April 20, 2026
Lucid Diligence Brief: 10x Genomics launches Atera Platform
Lucid Diligence Brief: MeiraGTx re-acquires bota-vec rights from J&J
Lucid Diligence Brief: STORM Therapeutics $56 million Series C for Phase II in Sarcoma
Respiratory Today—April 17, 2026

TAGS

AC Immune AMONDYS 45 antisense oligonucleotide Behcet’s disease Bivamelagon Cardiac Rehab Cardiovascular Risk CGRP chronic disease prevention clinical operations Committee for Medicinal Products for Human Use Competitive Intelligence Process Dermatomyositis Duchenne MD Duvakitug Efsubaglutide Alpha ESC2025 Exosome Vaccines GEO-MVA GLP1 drugs healthcare tech IgG4 Related Disease Immedica KRAS Macular degeneration Mantle Cell Lymphoma med tech Medtronic Diabetes Metformin Microplastics microRNA neurosymbolic AI Nutrition Science OM336 OncotoX-AML pediatric rare disease psychosis Rare pediatric disease designation RelabotulinumtoxinA robotic surgery RRMS Rusfertide Sjögrens Disease Sonelokimab Tabelecleucel

Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

© 2026 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy